Pekka Sillanaukee

Chairman of Board, Ph.D, Adjunct Professor of medical biochemistry

Education & other studies:

Master of Natural Science, University of Jyväskylä, Natural Science Faculty, Dep. of Chemistry and Dep. of Cell Biology, 1988
Master of Science, University of Jyväskylä, Natural Science Faculty, Dep. of Chemistry and Dep. of Cell Biology 1989
Ph.D., University of Tampere, Medical Faculty, Dep. of Biomedical Science, 1992
Associate Professorship (docent) of Medical Biochemistry, University of Tampere, Medical Faculty, Tampere, 1993
Helsinki School of Economics and Business Administration, Center for Management Development, Management Executive Program, (TEJOKO 3), 1994
Stockholm School of Economics and Business Administration, executive Master of Business Administration (eMBA) education, 1998
Qualification for Assistant Professorship in Karolinska Institute, Stockholm, Sweden, 1998
Executive Management studies in London Business School 1998-1999

Selected positions of trust:

2007 –› Chairman, Ovumia Ltd, Tampere and Nova Vita Kliinik AS, Tallinn
2010 –› 2017 Chairman and member of the Board, Nordic Senior Services Ltd (Jalmari Oy, Hilmari Oy, Paavolakoti Oy, Palvelutähti Oy, Joutsenkulma Oy)
2008 – 2016 Deputy Chairman and board member, Innokas Group Oy Ltd, Kempele, Helsinki, Tallinn
2005 –› Chairman, OS-Service Oy, Tampere and ESO International A/S, Plc, Tallinn
2000 – 2001 Expert, National Institute of Health USA (NIH), Washigton
1998 – 2000 Consultant Axis-Shields Plc, Dundee, Scotland
1999 – 2003 Expert memberships in several committees in Confederation of Finnish industries (EK) and Finnish Bioindustry